Maryland Biotechnology Facility Stimulates Protein Engineering

Consortium's technology for synthetic protein engineering offers access to one of the next hot fields in biotechnology WASHINGTON -- Proteins! That's what his elders would tell Dustin Hoffman to pursue instead of plastics if the 1960s movie The Graduate were set in the 1990s. That's where the next revolution in man-made materials will be. And that's why the federal government, the University of Maryland, and local politicians have invested $8 million to set up a protein engineering laboratory,

Written byElizabeth Pennisi
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Consortium's technology for synthetic protein engineering offers access to one of the next hot fields in biotechnology
WASHINGTON -- Proteins! That's what his elders would tell Dustin Hoffman to pursue instead of plastics if the 1960s movie The Graduate were set in the 1990s. That's where the next revolution in man-made materials will be. And that's why the federal government, the University of Maryland, and local politicians have invested $8 million to set up a protein engineering laboratory, the Center for Advanced Research in Biotechnology (CARB), in Rockville, Md. They're betting that molecular biologists can tailor proteins to do exactly what they want them to do.

One day, scientists hope, these "synthetic" proteins will outperform their natural counterparts, just as polypropylene outdoes wool and cotton in keeping people warm today. As drugs, custom analogs should work at lower doses and cause fewer side effects. They will also be made into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies